Obesity and Resistance to Cancer Chemotherapy: Interacting Roles of Inflammation and Metabolic Dysregulation

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|4|458-463

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.4, 2014-10, pp. : 458-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic inflammation: Connecting obesity and insulin resistance

By Dali-Youcef Nassim  

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 242-253

Informa Healthcare

Access to resources Recommend Favorite

Obesity, Inflammation, and Insulin Resistance – A Mini-Review

By  

Gerontology, Vol. 55, Iss. 4, 2009-04 ,pp. : 379-386

Karger

Access to resources Recommend Favorite

Intrinsic resistance to chemotherapy in breast cancer

By Moulder Stacy  

Women's Health, Vol. 6, Iss. 6, 2010-11 ,pp. : 821-830

Future Medicine

Access to resources Recommend Favorite

The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer

By Vona-Davis Linda   Rose David  

Journal of Mammary Gland Biology and Neoplasia, Vol. 18, Iss. 3-4, 2013-12 ,pp. : 291-307

Springer Publishing Company

Access to resources Recommend Favorite

TLR9 regulates adipose tissue inflammation and obesity‐related metabolic disorders

By  

OBESITY, Vol. 23, Iss. 11, 2015-11 ,pp. : 2199-2206

John Wiley & Sons Inc

Access to resources Recommend Favorite